Finally, dihydropyrimidine dehydrogenase (DPD) deficiency, present in approximately 0.3% of the general population in western countries, has to be tested before adjuvant chemotherapy with fluoropyrimidines, to prevent severe toxicity and possible toxic death in deficient patients [32]. Here, DPYD is linked to hyperinsulinemic hypoglycemia, familial, 4.